Fig. 3From: Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in EthiopiaDeterministic sensitivity analysis results of caspofungin-initiated treatment versus fluconazole-initiated treatment with caspofungin as second-line treatment. CASPO: Caspofungin; FLU: Fluconazole; L-AmB: Liposomal amphotericin BBack to article page